143 related articles for article (PubMed ID: 10231420)
1. Clear cell chondrosarcoma: a pathological and immunohistochemical study.
Masui F; Ushigome S; Fujii K
Histopathology; 1999 May; 34(5):447-52. PubMed ID: 10231420
[TBL] [Abstract][Full Text] [Related]
2. Epithelial and cartilaginous differentiation in clear cell chondrosarcoma.
Matsuura S; Ishii T; Endo M; Takahashi Y; Setsu N; Yamamoto H; Tamiya S; Iwamoto Y; Oda Y
Hum Pathol; 2013 Feb; 44(2):237-43. PubMed ID: 22944296
[TBL] [Abstract][Full Text] [Related]
3. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in cartilaginous tumours: a marker for malignancy?
Kunisada T; Moseley JM; Slavin JL; Martin TJ; Choong PF
Pathology; 2002 Apr; 34(2):133-7. PubMed ID: 12009094
[TBL] [Abstract][Full Text] [Related]
5. Giant cell tumor of bone: an immunohistochemical comparative study.
Masui F; Ushigome S; Fujii K
Pathol Int; 1998 May; 48(5):355-61. PubMed ID: 9704342
[TBL] [Abstract][Full Text] [Related]
6. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein.
Chano T; Ishizawa M; Matsumoto K; Morimoto S; Hukuda S; Okabe H
Eur J Histochem; 1995; 39(1):21-30. PubMed ID: 7612954
[TBL] [Abstract][Full Text] [Related]
7. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
8. Chondroblastoma of bone. A clinical, radiological, light and immunohistochemical study.
Edel G; Ueda Y; Nakanishi J; Brinker KH; Roessner A; Blasius S; Vestring T; Müller-Miny H; Erlemann R; Wuisman P
Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):355-66. PubMed ID: 1384228
[TBL] [Abstract][Full Text] [Related]
9. [Clear cell chondrosarcoma: report of a case].
Shi HQ; Liu QW; Lou SX
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):498-9. PubMed ID: 17845769
[No Abstract] [Full Text] [Related]
10. Periosteal osteosarcoma and parosteal chondrosarcoma evaluated by double immunohistochemical staining. Report of 2 cases.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H
Acta Orthop Scand; 1994 Jun; 65(3):355-8. PubMed ID: 7518993
[TBL] [Abstract][Full Text] [Related]
11. Chondroblastoma: An Update.
Chen W; DiFrancesco LM
Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
[TBL] [Abstract][Full Text] [Related]
12. Clear cell chondrosarcoma of bone. A report of three cases with immunohistochemical and affinity histochemical observations.
Wang LT; Liu TC
Pathol Res Pract; 1993 May; 189(4):411-5. PubMed ID: 8351242
[TBL] [Abstract][Full Text] [Related]
13. Clear cell chondrosarcoma: a review of clinicopathologic characteristics, differential diagnoses, and patient management.
Alexiev BA; Vormittag-Nocito ER; Peabody TD; Samet J; Laskin WB
Hum Pathol; 2023 Sep; 139():126-134. PubMed ID: 37805864
[TBL] [Abstract][Full Text] [Related]
14. Receptor activator of NF-kappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment.
Huang L; Cheng YY; Chow LT; Zheng MH; Kumta SM
Mol Pathol; 2003 Apr; 56(2):116-20. PubMed ID: 12665629
[TBL] [Abstract][Full Text] [Related]
15. Expression of cartilage growth plate signalling molecules in chondroblastoma.
Romeo S; Bovée JV; Jadnanansing NA; Taminiau AH; Hogendoorn PC
J Pathol; 2004 Jan; 202(1):113-20. PubMed ID: 14694528
[TBL] [Abstract][Full Text] [Related]
16. Expression of connective tissue growth factor in cartilaginous tumors.
Shakunaga T; Ozaki T; Ohara N; Asaumi K; Doi T; Nishida K; Kawai A; Nakanishi T; Takigawa M; Inoue H
Cancer; 2000 Oct; 89(7):1466-73. PubMed ID: 11013359
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor-alpha receptor expression supports the growth of conventional chondrosarcoma and is associated with adverse outcome.
Sulzbacher I; Birner P; Trieb K; Mühlbauer M; Lang S; Chott A
Am J Surg Pathol; 2001 Dec; 25(12):1520-7. PubMed ID: 11717542
[TBL] [Abstract][Full Text] [Related]
18. Chondroblastoma and clear cell chondrosarcoma: radiological and MRI characteristics with histopathological correlation.
Kaim AH; Hügli R; Bonél HM; Jundt G
Skeletal Radiol; 2002 Feb; 31(2):88-95. PubMed ID: 11828329
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of 36 cases of chondroblastomas: A single institutional experience.
Rekhi B; Ghate S; Shah A; Ramadwar M; Gulia A
Ann Diagn Pathol; 2020 Feb; 44():151440. PubMed ID: 31862519
[TBL] [Abstract][Full Text] [Related]
20. De-differentiated chondrosarcoma is not a 'de-differentiated' chondrosarcoma.
Aigner T; Dertinger S; Neureiter D; Kirchner T
Histopathology; 1998 Jul; 33(1):11-9. PubMed ID: 9726043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]